A committee has recently been set up, under the aegis of the European Chemical Industry Council (CEFIC), to represent European manufacturers of bulk pharmaceutical chemicals (BPCs).
The BPC Committee will serve as a forum for scientific, technological, quality and regulatory issues in the area of BPCs, and provide representation with intergovernmental bodies for European producers of pharmacologically active and inactive substances for use in pharmacological dosage forms. Its fields of activity are regulatory affairs, quality assurance and Good Manufacturing Practice, and pharmacopoeial matters.
Mr C van der Vlies of Gist Brocades in the Netherlands has been elected as chairman of the Committee, with Mr D Trottmann, representing SICOS of France, as vice chairman. For further details contact Rodolphe Schmitt at the CEFIC Secretariat, 4 avenue E Van Nieuwenhuyse, Bte 2, B - 1160 Brussels. Tel 32 2 676 72 41; fax 32 2 676 73 01.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze